Physician profile
Eugene Crafton
NPI 1508874850
$1,992.24
in general payments reported to CMS, 2019-2025
19 companies · $86.27 in 2025
The $86.27 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $366 · 2021: $820 · 2022: $72.42 · 2023: $22.47 · 2025: $86.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $672.73 | 2019-2023 | Rinvoq, Skyrizi |
| Gilead Sciences, INC. | $394.74 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $221.64 | 2019-2025 | Entyvio |
| Pfizer INC. | $141.55 | 2019-2020 | |
| Janssen Biotech, INC. | $127.09 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $78.25 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.56 | 2019-2021 | |
| Daiichi Sankyo INC. | $44.38 | 2021 | |
| Shire North American Group INC | $39.14 | 2019 | |
| Nestle Healthcare Nutrition INC. | $37.43 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $32.70 | 2025 | Dupixent |
| Celgene Corporation | $23.81 | 2021 | |
| Merck Sharp & Dohme LLC | $19.66 | 2021 | |
| Celltrion USA INC. | $16.86 | 2025 | Vegzelma |
| Ferring Pharmaceuticals INC. | $15.55 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.44 | 2025 | |
| Ucb, INC. | $13.30 | 2019 | |
| Olympus America INC. | $12.69 | 2019 | |
| Braintree Laboratories, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Crafton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.